StreetInsider.com News Articles

Form DEFA14A Anika Therapeutics, Inc.

Mon, 08 Jun 2026 09:26:00 -0400

si-local-file:///var/storage/secattach/20260608/26615252.html

Form DEFA14A Anika Therapeutics, Inc.

Mon, 08 Jun 2026 09:26:00 -0400

si-local-file:///var/storage/secattach/20260608/26615252.html

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fri, 05 Jun 2026 17:00:00 -0400

BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on June 1, 2026, Anika granted restricted stock units (“RSUs”) covering an aggregate of 3,360 shares of common stock to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors,

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fri, 05 Jun 2026 17:00:00 -0400

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fri, 05 Jun 2026 17:00:00 -0400

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fri, 05 Jun 2026 17:00:00 -0400

Form 4 Anika Therapeutics, Inc. For: Jun 03 Filed by: Griffin Stephen D.

Fri, 05 Jun 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260605/26610986.html

Form 4 Anika Therapeutics, Inc. For: Jun 03 Filed by: Griffin Stephen D.

Fri, 05 Jun 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260605/26610986.html

Form DEFA14A Anika Therapeutics, Inc.

Mon, 01 Jun 2026 11:13:00 -0400

si-local-file:///var/storage/secattach/20260601/26581189.html

Form DEFA14A Anika Therapeutics, Inc.

Mon, 01 Jun 2026 11:13:00 -0400

si-local-file:///var/storage/secattach/20260601/26581189.html

Form 4 Anika Therapeutics, Inc. For: May 01 Filed by: HENNEMAN JOHN B III

Mon, 04 May 2026 08:34:00 -0400

si-local-file:///var/storage/secattach/20260504/26421804.html

Form 4 Anika Therapeutics, Inc. For: May 01 Filed by: HENNEMAN JOHN B III

Mon, 04 May 2026 08:34:00 -0400

si-local-file:///var/storage/secattach/20260504/26421804.html

Form 4 Anika Therapeutics, Inc. For: Apr 30 Filed by: Griffin Stephen D.

Thu, 30 Apr 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260430/26410278.html

Form 4 Anika Therapeutics, Inc. For: Apr 30 Filed by: Griffin Stephen D.

Thu, 30 Apr 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260430/26410278.html

TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter